<?xml version="1.0" encoding="UTF-8"?>
<p id="p0165">In regions where HBV vaccine programs have not been instituted, many individuals will develop chronic hepatitis B. The availability of direct-acting antiviral agents to treat acute hepatitis C virus infections is likely to dramatically reduce the prevalence of chronic hepatitis C in the future.</p>
